Systems biology approach to identification of biomarkers for metastatic progression in cancer

BMC Bioinformatics

Volumn 9, Issue SUPPL. 9, 2008, Pages

  Ptitsyn, Andrey A ^a   Weil, Michael M ^a   Thamm, Douglas H ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; CELL CYCLE REGULATION; GENE EXPRESSION PATTERNS; GENE INTERACTION NETWORKS; IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES; MOLECULAR MECHANISM; OXIDATIVE PHOSPHORYLATION; THERAPEUTIC INTERVENTION;

ACTIVE NETWORKS; DIAGNOSIS; DISEASES; METABOLISM; PATHOLOGY; TUMORS;

GENE EXPRESSION;

TUMOR MARKER; TUMOR PROTEIN;

ANTIGEN PRESENTATION; CANCER GROWTH; CELL ADHESION; CELL CYCLE PROGRESSION; CLINICAL ASSESSMENT TOOL; CONFERENCE PAPER; CYTOSKELETON; DATA BASE; ENERGY METABOLISM; GENE EXPRESSION; GENE IDENTIFICATION; GENE INTERACTION; GENE TARGETING; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; METASTASIS POTENTIAL; MOLECULAR BIOLOGY; OXIDATIVE PHOSPHORYLATION; SOLID TUMOR; SYSTEMS BIOLOGY; ALGORITHM; ARTICLE; AUTOMATED PATTERN RECOGNITION; BIOLOGICAL MODEL; COMPUTER SIMULATION; DISEASE COURSE; GENE EXPRESSION PROFILING; HUMAN; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ALGORITHMS; COMPUTER SIMULATION; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PATTERN RECOGNITION, AUTOMATED; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 49649105570     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-9-S9-S8     Document Type: Conference Paper

References (58)

1. Onn A Fidler IJ Metastatic potential of human neoplasms In Vivo 2002, 16(6):423-429. 12494885
2. Fidler IJ The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited Nat Rev Cancer 2003, 3(6):453-458. 10.1038/nrc1098 12778135
3. Fidler IJ Kripke ML Metastasis results from preexisting variant cells within a malignant tumor Science 1977, 197(4306):893-895. 10.1126/ science.887927 887927
4. Liu R Wang X Chen GY Dalerba P Gurney A Hoey T Sherlock G Lewicki J Shedden K Clarke MF The prognostic role of a gene signature from tumorigenic breast-cancer cells N Engl J Med 2007, 356(3):217-226. 10.1056/NEJMoa063994 17229949
5. Parker B Sukumar S Distant metastasis in breast cancer: Molecular mechanisms and therapeutic targets Cancer Biol Ther 2003, 2(1):14-21. 12673112
6. Provenzani A Fronza R Loreni F Pascale A Amadio M Quattrone A Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis Carcinogenesis 2006, 27(7):1323-1333. 10.1093/carcin/bgi377 16531451
7. Ramaswamy S Ross KN Lander ES Golub TR A molecular signature of metastasis in primary solid tumors Nat Genet 2003, 33(1):49-54. 10.1038/ ng1060 12469122
8. van 't Veer LJ Dai H Vijver van de MJ He YD Hart AA Mao M Peterse HL Kooy van der K Marton MJ Witteveen AT Gene expression profiling predicts clinical outcome of breast cancer Nature 2002, 415(6871):530-536. 10.1038/415530a 11823860
9. Fidler IJ Modulation of the organ microenvironment for treatment of cancer metastasis J Natl Cancer Inst 1995, 87(21):1588-1592. 10.1093/ jnci/87.21.1588 7563201
10. Hunter K Host genetics influence tumour metastasis Nat Rev Cancer 2006, 6(2):141-146. 10.1038/nrc1803 16491073
11. Crawford NP Hunter KW New perspectives on hereditary influences in metastatic progression Trends Genet 2006, 22(10):555-561. 10.1016/ j.tig.2006.07.009 16889869
12. LaTulippe E Satagopan J Smith A Scher H Scardino P Reuter V Gerald WL Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease Cancer Res 2002, 62(15):4499-4506. 12154061
13. Scher HI Heller G Clinical states in prostate cancer: Toward a dynamic model of disease progression Urology 2000, 55(3):323-327. 10.1016/ S0090-4295(99)00471-9 10699601
14. Fidler IJ Molecular biology of cancer: Invasion and metastasis Cancer Principles and Practice of Oncology Philadelphia: Lippincott-Raven DeVita VT, Hellman, S, Rosenberg SA 1997, 135-152.
15. Draghici S Khatri P Martins RP Ostermeier GC Krawetz SA Global functional profiling of gene expression Genomics 2003, 81(2):98-104. 10.1016/S0888-7543(02)00021-6 12620386
16. Manoli T Gretz N Grone HJ Kenzelmann M Eils R Brors B Group testing for pathway analysis improves comparability of different microarray datasets Bioinformatics 2006, 22(20):2500-2506. 10.1093/bioinformatics/btl424 16895928
17. Subramanian A Tamayo P Mootha VK Mukherjee S Ebert BL Gillette MA Paulovich A Pomeroy SL Golub TR Lander ES Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci USA 2005, 102(43):15545-15550. 1239896 16199517 10.1073/pnas.0506580102
18. Barry WT Nobel AB Wright FA Significance analysis of functional categories in gene expression studies: A structured permutation approach Bioinformatics 2005, 21(9):1943-1949. 10.1093/bioinformatics/bti260 15647293
19. Bolstad BM Irizarry RA Astrand M Speed TP A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 2003, 19(2):185-193. 10.1093/bioinformatics/ 19.2.185 12538238
20. Patel S Lyons-Weiler J caGEDA: A web application for the integrated analysis of global gene expression patterns in cancer Appl Bioinformatics 2004, 3(1):49-62. 16323966
21. Huang da W Sherman BT Tan Q Collins JR Alvord WG Roayaei J Stephens R Baseler MW Lane HC Lempicki RA The DAVID Gene Functional Classification Tool: A novel biological module-centric algorithm to functionally analyze large gene lists Genome Biol 2007, 8(9):R183. 2375021 17784955 10.1186/gb-2007-8-9-r183
22. Warburg O Uber den Stoffwechsel der Carcinomzelle Klin Wochenschr 1925, 4:534-536. 10.1007/BF01726151
23. Warburg O On the origin of cancer cells Science 1956, 123:309-314. 10.1126/science.123.3191.309 13298683
24. Warburg O On respiratory impairment in cancer cells Science 1956. 124:269-270. 13351639
25. Amuthan G Biswas G Ananadatheerthavarada HK Vijayasarathy C Shephard HM Avadhani NG Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells Oncogene 2002, 21(51):7839-7849. 10.1038/sj.onc.1205983 12420221
26. Harris MH Vander Heiden MG Kron SJ Thompson CB Role of oxidative phosphorylation in Bax toxicity Mol Cell Biol 2000, 20(10):3590-3596. 85651 10779348 10.1128/MCB.20.10.3590-3596.2000
27. Dey R Moraes CT Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells J Biol Chem 2000, 275(10):7087-7094. 10.1074/jbc.275.10.7087 10702275
28. Gmeiner WH Hellmann GM Shen P Tissue-dependent and -independent gene expression changes in metastatic colon cancer Oncol Rep 2008. 19(1):245-251. 18097602
29. Lin HM Chatterjee A Lin YH Anjomshoaa A Fukuzawa R McCall JL Reeve AE Genome wide expression profiling identifies genes associated with colorectal liver metastasis Oncol Rep 2007, 17(6):1541-1549. 17487416
30. Cuezva JM Chen G Alonso AM Isidoro A Misek DE Hanash SM Beer DG The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis Carcinogenesis 2004, 25(7):1157-1163. 10.1093/carcin/bgh113 14963017
31. Cuezva JM Krajewska M de Heredia ML Krajewski S Santamaria G Kim H Zapata JM Marusawa H Chamorro M Reed JC The bioenergetic signature of cancer: A marker of tumor progression Cancer Res 2002, 62(22):6674-6681. 12438266
32. Airley RE Mobasheri A Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: Novel pathways and targets for anticancer therapeutics Chemotherapy 2007, 53(4):233-256. 10.1159/ 000104457 17595539
33. Cao X Jia G Zhang T Yang M Wang B Wassenaar PA Cheng H Knopp MV Sun D Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model Cancer Chemother Pharmacol 2008.
34. Duenas-Gonzalez A Candelaria M Perez-Plascencia C Perez-Cardenas E de la Cruz-Hernandez E Herrera LA Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors Cancer Treat Rev 2008, 34(3):206-222. 10.1016/j.ctrv.2007.11.003 18226465
35. Hong IK Jin YJ Byun HJ Jeoung DI Kim YM Lee H Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways J Biol Chem 2006, 281(34):24279-24292. 10.1074/jbc.M601209200 16798740
36. Ang J Lijovic M Ashman LK Kan K Frauman AG CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: A new prognostic indicator? Cancer Epidemiol Biomarkers Prev 2004, 13(11 Pt 1):1717-1721. 15533898
37. Merajver SD Usmani SZ Multifaceted role of Rho proteins in angiogenesis J Mammary Gland Biol Neoplasia 2005, 10(4):291-298. 10.1007/ s10911-006-9002-8 16900393
38. Wang D Dou K Xiang H Song Z Zhao Q Chen Y Li Y Involvement of RhoA in progression of human hepatocellular carcinoma J Gastroenterol Hepatol 2007, 22(11):1916-1920. 10.1111/j.1440-1746.2006.04534.x 17914970
39. Takami Y Higashi M Kumagai S Kuo PC Kawana H Koda K Miyazaki M Harigaya K The activity of RhoA is correlated with lymph node metastasis in human colorectal cancer Dig Dis Sci 2008, 53(2):467-473. 10.1007/ s10620-007-9887-0 17597401
40. Kamai T Tsujii T Arai K Takagi K Asami H Ito Y Oshima H Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer Clin Cancer Res 2003, 9(7):2632-2641. 12855641
41. Chai LX Sun KL Guo LP Zhang HT Lu SX Expression of ezrin and CD44-v6 in human esophageal squamous cell carcinoma and its clinical significance Zhonghua Zhong Liu Za Zhi 2007, 29(9):685-688. 18246799
42. Torer N Kayaselcuk F Nursal TZ Yildirim S Tarim A Noyan T Karakayali H Adhesion molecules as prognostic markers in pancreatic adenocarcinoma J Surg Oncol 2007, 96(5):419-423. 10.1002/jso.20654 17874463
43. Kobel M Gradhand E Zeng K Schmitt WD Kriese K Lantzsch T Wolters M Dittmer J Strauss HG Thomssen C Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma Int J Gynecol Pathol 2006, 25(2):121-130. 10.1097/ 01.pgp.0000185410.39050.ac 16633060
44. Yeh TS Tseng JH Liu NJ Chen TC Jan YY Chen MF Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma Arch Surg 2005, 140(12):1184-1190. 10.1001/ archsurg.140.12.1184 16365240
45. Weng WH Ahlen J Astrom K Lui WO Larsson C Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas Clin Cancer Res 2005, 11(17):6198-6204. 10.1158/ 1078-0432.CCR-05-0548 16144921
46. Khanna C Wan X Bose S Cassaday R Olomu O Mendoza A Yeung C Gorlick R Hewitt SM Helman LJ The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nat Med 2004, 10(2):182-186. 10.1038/nm982 14704791
47. Kelley LC Shahab S Weed SA Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer Clin Exp Metastasis 2008. 18324357
48. Mandal M Myers JN Lippman SM Johnson FM Williams MD Rayala S Ohshiro K Rosenthal DI Weber RS Gallick GE Epithelial to mesenchymal transition in head and neck squamous carcinoma: Association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features Cancer 2008, 112(9):2088-2100. 10.1002/cncr.23410 18327819
49. Xue F Zhang JJ Qiu F Zhang M Chen XS Li QG Han LZ Xi ZF Xia Q Rho signaling inhibitor, Y-2 inhibits invasiveness of metastastic hepatocellular carcinoma in a mouse model Chin Med J (Engl) 7632, 120(24):2304-2307.
50. Evelyn CR Wade SM Wang Q Wu M Iniguez-Lluhi JA Merajver SD Neubig RR CCG-1423: A small-molecule inhibitor of RhoA transcriptional signaling Mol Cancer Ther 2007, 6(8):2249-2260. 10.1158/1535-7163.MCT-06-0782 17699722
51. Wan X Mendoza A Khanna C Helman LJ Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma Cancer Res 2005, 65(6):2406-2411. 10.1158/0008-5472.CAN-04-3135 15781656
52. Khan AN Magner WJ Tomasi TB An epigenetic vaccine model active in the prevention and treatment of melanoma J Transl Med 2007, 5(1):64. 2231344 18070359 10.1186/1479-5876-5-64
53. Khan AN Gregorie CJ Tomasi TB Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells Cancer Immunol Immunother 2008, 57(5):647-654. 10.1007/ s00262-007-0402-4 18046553
54. Manning J Indrova M Lubyova B Pribylova H Bieblova J Hejnar J Simova J Jandlova T Bubenik J Reinis M Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours Immunology 2008, 123(2):218-227. 17725605
55. Benjamini YaH Y Controlling the false discovery rate: A practical and powerful approach to multiple testing J Roy Stat Soc B 1995, 57:289-300.
56. Storey JD Tibshirani R Statistical methods for identifying differentially expressed genes in DNA microarrays Methods Mol Biol 2003, 224:149-157. 12710672
57. Adrian Mondry ML Alessandro Giuliani DNA expression microarrays may be the wrong tool to identify biological pathways Nature Preceedings 2007.
58. Tong W Cao X Harris S Sun H Fang H Fuscoe J Harris A Hong H Xie Q Perkins R ArrayTrack - supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research Environ Health Perspect 2003, 111(15):1819-1826. 1241745 14630514